• P-ISSN2233-4203
  • E-ISSN2093-8950
  • ESCI, SCOPUS, KCI

Article Detail

Home > Article Detail
  • P-ISSN 2233-4203
  • E-ISSN 2093-8950

A Method to Monitor Dutasteride in Rat Plasma Using Liquid-Liquid Extraction and Multiple Reaction Monitoring: Comparisons and Validation

Mass Spectrometry Letters / Mass Spectrometry Letters, (P)2233-4203; (E)2093-8950
2014, v.5 no.3, pp.79-83
https://doi.org/10.5478/MSL.2014.5.3.79
Kang Myung Joo (Dankook University)
Cho Ha Ra (Dankook University)
Lee Dong Hoon (Chung-Ang University)
Yeom Dong Woo (Chung-Ang University)
Choi Young Wook (Chung-Ang University)
Choi Yong Seok (Dankook University)
  • Downloaded
  • Viewed

Abstract

Three different dutasteride extraction methods were compared and a method based on liquid-liquid extraction (LLE)using methyl tert-butyl ether and methylene chloride was proved to be more effective than others for the extraction of dutasterideand finasteride, the internal standard (IS), from rat plasma. Additionally, a method composed of the LLE extraction, liquid chromatography,and multiple reaction monitoring (MRM) to target dutasteride and IS was validated by assessing specificity, linearity(r2 = 0.9993, 5 - 400 ng/mL), sensitivity (the limit of detection: 4.03 ng/mL; the limit of quantitation: 12.10 ng/mL), accuracy(intra-day: 89.4 - 105.9%; inter-day: 84.9 - 100.9%), precision (intra-day: 0.8 - 6.9%; inter-day: 2.9 - 15.9%), and recovery (84.7- 107.8%). Since the validated method was successfully applied to a pharmacokinetic study of dutasteride, it can be useful for thepharmacokinetic evaluation of newly developed dutasteride formulations.

keywords
dutasteride, multiple reaction monitoring, rat plasma


Reference

1

Gisleskog, P. O.. (1999). . Br. J. Clin. Pharmacol, 47, 53-.

2

Evans, H. C.. (2003). . Drugs Aging, 20, 905-.

3

Gaines, K. K.. (2003). . Urol. Nurs, 23, 218-.

4

Brown, C. T.. (2003). . Int. J. Clin. Pract, 57, 705-.

5

Olsson, G. P.. (1999). . Eur. J. Pharm. Sci, 8, 291-.

6

Olsen, E. A.. (2006). . J. Am. Acad. Dermatol, 55, 1014-.

7

U. S. Food Drug Administration. (2012). Application Number:21-319. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21319_Duagen_biopharmr_P1.pdf.

8

Ofner, C. M. 3rd.. (2001). . J. Pharm. Sci, 90, 79-.

9

Ramakrishna, N. V. S.. (2004). . J. Chromatogr. B, 809, 117-.

10

Gomes, N. A.. (2009). . Chromatographia, 69, 9-.

11

Baek, I. -H.. (2012). . Chem. Pharm. Bull, 60, 1468-.

12

Contractor, P.. (2013). . Biomed. Chromatogr, 27, 1168-.

Submission Date
2014-05-29
Revised Date
2014-06-05
Accepted Date
2014-06-05
상단으로 이동

Mass Spectrometry Letters